Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the impact of adjunctive metformin therapy on glycemic control in overweight/obese youth with type 1 diabetes, finding no significant differences in key outcomes.
This study investigated the impact of non-surgical periodontal therapy on renal function and glycaemic control in chronic kidney disease patients, finding significant improvements in eGFR and HbA1c levels.
This Phase 2 trial evaluated tirzepatide in adults with type 1 diabetes and obesity, showing significant weight loss and insulin dose reduction.
This study evaluated the short-term effects of tofogliflozin on insulin secretory capacity in type 2 diabetes. It found significant improvements in several metabolic markers.
This study evaluated an AI-based insulin decision support system against standard therapy by senior endocrinologists for managing Type 2 diabetes. The AI system showed comparable glycemic outcomes.
This study evaluated a cloud-based platform for developing algorithms for type 1 diabetes using various artificial pancreas systems. It found slight improvements in glucose management metrics.
This study evaluated the effects of therapeutic ultrasound on muscle soreness and fatigue in women with type 2 diabetes. Results indicated significant reductions in pain and fatigue levels.
This study evaluated the outcomes of endoscopic partial jejunal diversion using a self-assembling magnetic anastomosis system over 36 months, finding significant weight loss and improvements in glycemic control.
This study evaluated the feasibility of a culturally adapted lifestyle intervention for preventing Type 2 diabetes in Brazil, finding significant improvements in diet quality.
The study evaluated CT-868, a dual GLP-1/GIP receptor agonist, and found it significantly improved glycaemic control in adults with type 2 diabetes.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
